Description
Eloralintide 10mg
Eloralintide 10mg is a novel investigational peptide being studied for its potential applications in metabolic health, appetite regulation, energy balance, and weight-management research. As a long-acting amylin receptor agonist, eloralintide is designed to interact with biological pathways associated with satiety and appetite control. Researchers are evaluating its potential effects on food intake, metabolic function, and body-weight regulation.
Amylin is a naturally occurring peptide hormone involved in the regulation of appetite and post-meal metabolic responses. By targeting amylin-related pathways, eloralintide is being investigated for its ability to influence feelings of fullness and potentially reduce food consumption. Its long-acting profile makes it an interesting compound for researchers studying sustained appetite-regulation mechanisms and metabolic signaling.
Uther Peptides Eloralintide 10mg is presented as a research-grade product with a stated purity of ≥99%. The compound is intended for laboratory and scientific research applications and should not be represented as an approved medication or established treatment. Ongoing research continues to investigate its pharmacological characteristics, biological activity, tolerability, and potential applications.
Product Specifications
- Product Name: Eloralintide 10mg
- Molecular Formula: C₁₈₈H₂₉₁N₅₁O₅₉
- Molecular Weight: 4136.73 g/mol
- Purity: ≥99%
- Peptide Sequence: H-Lys-Pro-Gly-Lys-Val-Gly-Lys-Lys-Asn-Gly-Ser-Ser-Gly-Thr-Pro-Val-Leu-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂
Eloralintide is of particular interest within current metabolic research because of its potential relationship with appetite and energy-regulation pathways. Scientific investigations are examining how amylin receptor activation may contribute to satiety signaling and changes in food intake. Researchers are also exploring how compounds in this class may interact with broader metabolic processes.
The 10mg research format provides researchers with a defined quantity of the compound for controlled laboratory investigations. Proper storage, handling, analytical verification, and laboratory protocols should be determined according to the requirements of the specific research application.
As an investigational compound, eloralintide has not been established as a treatment for obesity, diabetes, or any other medical condition. Research findings may evolve as additional studies become available, and laboratory or clinical results should be interpreted by qualified professionals.
Uther Peptides provides Eloralintide 10mg as a research-oriented peptide product for qualified scientific applications. Researchers interested in metabolic signaling, appetite regulation, amylin biology, and energy-balance pathways may find eloralintide relevant to ongoing laboratory investigations.
For research use only. Not for human consumption or self-administration.
